Cabotegravir and lenacapravir are two antiretroviral drugs used in the treatment of HIV infection. During the webinar, pharmacists and nurses will be educated on the mechanism of action, pharmacokinetics, and administration of these drugs. The speakers will also discuss the appropriate patient population for use, potential adverse effects, and drug interactions. The webinar will emphasize the importance of monitoring patients receiving cabotegravir and lenacapravir and the role of pharmacists and nurses in ensuring safe and effective use of these drugs.